My NCBI | Sign In
RSS Settings
  • Search: Hudson BI[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 27

    1.

    Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.

    Tekabe Y, Li Q, Rosario R, Sedlar M, Majewski S, Hudson BI, Einstein AJ, Schmidt AM, Johnson LL.

    Circ Cardiovasc Imaging. 2008 Nov;1(3):212-9.PMID: 19808545 [PubMed - indexed for MEDLINE]Related articles

    2.

    Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases.

    Maillard-Lefebvre H, Boulanger E, Daroux M, Gaxatte C, Hudson BI, Lambert M.

    Rheumatology (Oxford). 2009 Oct;48(10):1190-6. Epub 2009 Jul 9. Review.PMID: 19589888 [PubMed - indexed for MEDLINE]Related articles

    3.

    Percutaneous cell delivery into the heart using hydrogels polymerizing in situ.

    Martens TP, Godier AF, Parks JJ, Wan LQ, Koeckert MS, Eng GM, Hudson BI, Sherman W, Vunjak-Novakovic G.

    Cell Transplant. 2009;18(3):297-304.PMID: 19558778 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    RAGE: a novel biological and genetic marker for vascular disease.

    Kalea AZ, Schmidt AM, Hudson BI.

    Clin Sci (Lond). 2009 Apr;116(8):621-37. Review.PMID: 19275767 [PubMed - indexed for MEDLINE]Related articles

    5.

    Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene.

    Kalea AZ, Reiniger N, Yang H, Arriero M, Schmidt AM, Hudson BI.

    FASEB J. 2009 Jun;23(6):1766-74. Epub 2009 Jan 22.PMID: 19164451 [PubMed - indexed for MEDLINE]Related articles

    6.

    Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42.

    Hudson BI, Kalea AZ, Del Mar Arriero M, Harja E, Boulanger E, D'Agati V, Schmidt AM.

    J Biol Chem. 2008 Dec 5;283(49):34457-68. Epub 2008 Oct 15.PMID: 18922799 [PubMed - indexed for MEDLINE]Related articles

    7.

    Identification, classification, and expression of RAGE gene splice variants.

    Hudson BI, Carter AM, Harja E, Kalea AZ, Arriero M, Yang H, Grant PJ, Schmidt AM.

    FASEB J. 2008 May;22(5):1572-80. Epub 2007 Dec 18.PMID: 18089847 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice.

    Harja E, Bu DX, Hudson BI, Chang JS, Shen X, Hallam K, Kalea AZ, Lu Y, Rosario RH, Oruganti S, Nikolla Z, Belov D, Lalla E, Ramasamy R, Yan SF, Schmidt AM.

    J Clin Invest. 2008 Jan;118(1):183-94.PMID: 18079965 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    RAGE ligand upregulation of VEGF secretion in ARPE-19 cells.

    Ma W, Lee SE, Guo J, Qu W, Hudson BI, Schmidt AM, Barile GR.

    Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1355-61.PMID: 17325184 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The ligand/RAGE axis: lighting the fuse and igniting vascular stress.

    Yan SF, Naka Y, Hudson BI, Herold K, Yan SD, Ramasamy R, Schmidt AM.

    Curr Atheroscler Rep. 2006 May;8(3):232-9. Review.PMID: 16640960 [PubMed - indexed for MEDLINE]Related articles

    11.

    Diabetic vascular disease: it's all the RAGE.

    Hudson BI, Wendt T, Bucciarelli LG, Rong LL, Naka Y, Yan SF, Schmidt AM.

    Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1588-600. Review.PMID: 16356122 [PubMed - indexed for MEDLINE]Related articles

    12.

    RAGE polymorphisms and the heritability of insulin resistance: the Leeds family study.

    Sullivan CM, Futers TS, Barrett JH, Hudson BI, Freeman MS, Grant PJ.

    Diab Vasc Dis Res. 2005 Feb;2(1):42-4.PMID: 16305072 [PubMed - indexed for MEDLINE]Related articles

    13.

    RAGE and its ligands: a lasting memory in diabetic complications?

    Yan SF, Ramasamy R, Bucciarelli LG, Wendt T, Lee LK, Hudson BI, Stern DM, Lalla E, DU Yan S, Rong LL, Naka Y, Schmidt AM.

    Diab Vasc Dis Res. 2004 May;1(1):10-20. Review.PMID: 16305050 [PubMed - indexed for MEDLINE]Related articles

    14.

    The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study.

    Hofmann MA, Yang Q, Harja E, Kedia P, Gregersen PK, Cupples LA, Schmidt AM, Hudson BI.

    Atherosclerosis. 2005 Oct;182(2):301-5.PMID: 16159602 [PubMed - indexed for MEDLINE]Related articles

    15.

    The RAGE axis in early diabetic retinopathy.

    Barile GR, Pachydaki SI, Tari SR, Lee SE, Donmoyer CM, Ma W, Rong LL, Buciarelli LG, Wendt T, Hörig H, Hudson BI, Qu W, Weinberg AD, Yan SF, Schmidt AM.

    Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2916-24.PMID: 16043866 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.

    Kim W, Hudson BI, Moser B, Guo J, Rong LL, Lu Y, Qu W, Lalla E, Lerner S, Chen Y, Yan SS, D'Agati V, Naka Y, Ramasamy R, Herold K, Yan SF, Schmidt AM.

    Ann N Y Acad Sci. 2005 Jun;1043:553-61. Review.PMID: 16037278 [PubMed - indexed for MEDLINE]Related articles

    17.

    Soluble RAGE: a hot new biomarker for the hot joint?

    Moser B, Hudson BI, Schmidt AM.

    Arthritis Res Ther. 2005;7(4):142-4. Epub 2005 Jun 3.PMID: 15987496 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein?

    Hudson BI, Harja E, Moser B, Schmidt AM.

    Arterioscler Thromb Vasc Biol. 2005 May;25(5):879-82. No abstract available. PMID: 15863717 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    RAGE: a novel target for drug intervention in diabetic vascular disease.

    Hudson BI, Schmidt AM.

    Pharm Res. 2004 Jul;21(7):1079-86. Review.PMID: 15290845 [PubMed - indexed for MEDLINE]Related articles

    20.

    Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders.

    Hudson BI, Bucciarelli LG, Wendt T, Sakaguchi T, Lalla E, Qu W, Lu Y, Lee L, Stern DM, Naka Y, Ramasamy R, Yan SD, Yan SF, D'Agati V, Schmidt AM.

    Arch Biochem Biophys. 2003 Nov 1;419(1):80-8. Review.PMID: 14568011 [PubMed - indexed for MEDLINE]Related articles

    21.

    Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy.

    Wendt T, Tanji N, Guo J, Hudson BI, Bierhaus A, Ramasamy R, Arnold B, Nawroth PP, Yan SF, D'Agati V, Schmidt AM.

    J Am Soc Nephrol. 2003 May;14(5):1383-95. Review.PMID: 12707408 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients.

    Pettersson-Fernholm K, Forsblom C, Hudson BI, Perola M, Grant PJ, Groop PH; Finn-Diane Study Group.

    Diabetes. 2003 Mar;52(3):891-4.PMID: 12606536 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response.

    Hofmann MA, Drury S, Hudson BI, Gleason MR, Qu W, Lu Y, Lalla E, Chitnis S, Monteiro J, Stickland MH, Bucciarelli LG, Moser B, Moxley G, Itescu S, Grant PJ, Gregersen PK, Stern DM, Schmidt AM.

    Genes Immun. 2002 May;3(3):123-35.PMID: 12070776 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Characterization of allelic and nucleotide variation between the RAGE gene on chromosome 6 and a homologous pseudogene sequence to its 5' regulatory region on chromosome 3: implications for polymorphic studies in diabetes.

    Hudson BI, Stickland MH, Grant PJ, Futers TS.

    Diabetes. 2001 Dec;50(12):2646-51.PMID: 11723045 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Study of the -429 T/C and -374 T/A receptor for advanced glycation end products promoter polymorphisms in diabetic and nondiabetic subjects with macrovascular disease.

    Hudson BI, Stickland MH, Futers TS, Grant PJ.

    Diabetes Care. 2001 Nov;24(11):2004. No abstract available. PMID: 11679477 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy.

    Hudson BI, Stickland MH, Futers TS, Grant PJ.

    Diabetes. 2001 Jun;50(6):1505-11.PMID: 11375354 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups.

    Hudson BI, Stickland MH, Grant PJ.

    Diabetes. 1998 Jul;47(7):1155-7. Review. No abstract available. PMID: 9648842 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    3 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity